-

CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of CVRx Inc. (“CVRx” or the “Company”) (NASDAQ:CVRX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

[LEARN MORE ABOUT THE INVESTIGATION]

What Happened?

On April 7, 2025, CVRx announced weaker than expected preliminary first quarter results. In the Company’s earnings press release, CVRx’s President and Chief Executive Officer Kevin Hykes (“Hykes”) said that “many of [the Company’s] newer sales representatives are still in the early stages of development.” On this news, the price of CVRx shares declined by $5.34 per share, or approximately 46.3%, from $11.54 per share on April 7, 2025 to close at $6.20 on April 8, 2025.

Then, on May 8, 2025, CVRx announced weak first quarter results and lowered its full year revenue guidance. During the related earnings call, CEO Hykes said that recent salesforce changes at the Company were “more significant than initially anticipated and resulted in 25% of our current territory managers being hired between December and March.” On this news, the price of CVRx shares declined by $3.01 per share, or approximately 38.8%, from $7.78 per share on May 8, 2025 to close at $4.77 on May 9, 2025.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired CVRx securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:CVRX

Release Versions

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

UNIQURE N.V. QURE INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 37.3% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On September 29, 2026, uniQure released 48-month data for ongoing Phase I/II studies of AMT-130, the Compan...

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On June 2, 2026, the FDA published a warning letter that detailed Medline’s “significant violations of Curr...

Securities Class Action Filed Against Alphabet Inc. – GOOGL/GOOG Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOGL; GOOG) securities between May 19, 2026 and July 16, 2026, inclusive (“the Class Period”). If you suffered a loss on your Alphabet investments, you have until December 1, 2026 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are encouraged to fill ou...
Back to Newsroom